LONG TERM BREAKOUT AFTER 2017. A GOOD POSITION TO BUY THIS STOCK. FURTHER RALLY IN PHARMA SECTOR SHOULD HELP WITH THE RUN.
Trade active
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
